Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.340.360.360.340.34

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.34 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.34
Mar20240.36
Mar20230.36
Mar20220.34
Mar20210.34

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.34
-5.56
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34
0.00
Mar2021 0.34 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,360.2 Cr -0.9% 3.6% 36.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹98,210.2 Cr -1.7% -8.4% -16.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.9%

3.6%

36.7%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses